Martin Ullrich

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Cancers

Endocrine-related cancer

Pharmaceutics

ChemMedChem

Helmholtz-Zentrum Dresden-Rossendorf

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz-Zentrum Dresden-Rossendorf May 08 2012

Germany

Research Associate :: Institute of Radiopharmaceutical Cancer Research

Publications

Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R Loureiro, Klaus Kopka, Sven Stadlbauer
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers 15 (9) (2023)
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R Loureiro, Klaus Kopka, Sven Stadlbauer
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers 15 (9) (2023)
Austin Craig, Jürgen Kogler, Markus Laube, Martin Ullrich, Cornelius K Donat, Robert Wodtke, Klaus Kopka, Sven Stadlbauer
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction. Pharmaceutics 15 (12) (2023)
Austin Craig, Jürgen Kogler, Markus Laube, Martin Ullrich, Cornelius K Donat, Robert Wodtke, Klaus Kopka, Sven Stadlbauer
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction. Pharmaceutics 15 (12) (2023)
Franziska Striese, Christin Neuber, Sandy Gräßel, Claudia Arndt, Martin Ullrich, Jörg Steinbach, Jens Pietzsch, Ralf K Bergmann, Hans-Jürgen Pietzsch, Wiebke Sihver, Marcus Frenz, Anja Feldmann, Michael Philipp Bachmann
Preclinical Characterization of the 177 Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5. International journal of molecular sciences 24 (11) (2023)
Florian Brandt, Martin Ullrich, Verena Seifert, Cathleen Haase-Kohn, Susan Richter, Torsten Kniess, Jens Pietzsch, Markus Laube
Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells. Molecules (Basel, Switzerland) 27 (19) (2022)
Katharina Wang, Ina Schütze, Sebastian Gulde, Nicole Bechmann, Susan Richter, Jana Helm, Michael Lauseker, Julian Maurer, Astrid Reul, Gerald Spoettl, Barbara Klink, Doreen William, Thomas Knösel, Juliane Friemel, Michel Bihl, Achim Weber, Maria Fankhauser, Laura Schober, Diana Vetter, Martina Broglie Däppen, Christian G Ziegler, Martin Ullrich, Jens Pietzsch, Stefan R Bornstein, Christian Lottspeich, Matthias Kroiss, Martin Fassnacht, Vera Ursula Julia Wenter, Roland Ladurner, Constanze Hantel, Martin Reincke, Graeme Eisenhofer, Ashley B Grossman, Karel Pacak, Felix Beuschlein, Christoph J Auernhammer, Natalia S Pellegata, Svenja Nölting
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. Endocrine-related cancer 29 (6) (2022)
Nicole Bechmann, Mats Leif Moskopp, Martin Ullrich, Bruna Calsina, Pål William Wallace, Susan Richter, Markus Friedemann, Katharina Langton, Stephanie M J Fliedner, Henri J L M Timmers, Svenja Nölting, Felix Beuschlein, Aleksander Prejbisz, Karel Pacak, Hans K Ghayee, Stefan R Bornstein, Peter Dieterich, Jens Pietzsch, Ben Wielockx, Mercedes Robledo, Nan Qin, Graeme Eisenhofer
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. Endocrine-related cancer 27 (11) (2021)
Ian Moore F Gilpin, Martin Ullrich, Thomas Erik Wuensche, Kristof Zarschler, Ondřej Lebeda, Jens Pietzsch, Hans-Jürgen Pietzsch, Martin Walther
Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics. ChemMedChem 16 (17) (2021)
Verena Seifert, Susan Richter, Nicole Bechmann, Michael Philipp Bachmann, Christian G Ziegler, Jens Pietzsch, Martin Ullrich
HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models. Cancers 13 (3) (2021)
Falco Reissig, David Bauer, Martin Ullrich, Martin Kreller, Jens Pietzsch, Constantin Mamat, Klaus Kopka, Hans-Jürgen Pietzsch, Martin Walther
Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging. Pharmaceuticals (Basel, Switzerland) 13 (10) (2020)
Markus Laube, Cemena Gassner, Christin Neuber, Robert Wodtke, Martin Ullrich, Cathleen Haase-Kohn, Reik Löser, Martin Köckerling, Klaus Kopka, Torsten Kniess, Evamarie Hey-Hawkins, Jens Pietzsch
Deuteration versus ethylation - strategies to improve the metabolic fate of an 18 F-labeled celecoxib derivative. RSC advances 10 (63) (2020)
Alina Doctor, Verena Seifert, Martin Ullrich, Sandra Hauser, Jens Pietzsch
Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research. Cancers 12 (10) (2020)
Nicole Bechmann, Isabel Poser, Verena Seifert, Christian Greunke, Martin Ullrich, Nan Qin, Axel Walch, Mirko Peitzsch, Mercedes Robledo, Karel Pacak, Jens Pietzsch, Susan Richter, Graeme Eisenhofer
Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells. Cancers 11 (5) (2019)
Martin Ullrich, Susan Richter, Verena Seifert, Sandra Hauser, Bruna Calsina, Ángel M Martínez-Montes, Marjolein Ter Laak, Christian G Ziegler, Henri Timmers, Graeme Eisenhofer, Mercedes Robledo, Jens Pietzsch
Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background. Cancers 11 (6) (2019)

Martin Ullrich.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Ullrich